Specialty· August 15, 2026 · 25 min read
Kidney Transplant Immunosuppression: Part B-ID Cliff, Tacrolimus, & Access
By Ran Chen#Nephrology#Medicare Part B#Coverage Access
Topic
Generic Drugs
Generic drug pricing, ANDA approvals, price erosion, NADAC benchmarking, and market access for unbranded pharmaceuticals.
Policy· August 12, 2026 · 38 min read
IARC Group 1 Call on HCTZ, Voriconazole, Tacrolimus: Pharma & P&T Actions
By Ran Chen#FDA#Label Warnings#Formulary Strategy
Pricing & Access· August 3, 2026 · 15 min read
EU Pharmaceutical Procurement by the Numbers (2026): What 35,000 TED Tenders Reveal
By Ran Chen#Market Access#Generic Drugs#Drug Pricing
Manufacturing· August 1, 2026 · 20 min read
FDA Warning Letters by the Numbers (2026): CDER Drug Enforcement Surge
Pricing & Access· August 1, 2026 · 23 min read
Parkinson's Disease Treatment Access: From $0.08 Levodopa to Tavapadon
Policy· July 28, 2026 · 22 min read
Trump's Generic Drug Tariff: The 2028–2029 Onshoring Timeline and US Import Exposure
By Ran Chen#Generic Drugs#Tariffs#Manufacturing